# Galega (Galega officinalis)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/galega
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-29
**Evidence Score:** 2 / 10
**Category:** European
**Also Known As:** Galega officinalis, goat's rue, French lilac, professor-weed, Italian fitch, Spanish sainfoin, false indigo, galega herb

## Overview

Galega officinalis contains metformin precursors like galegine that activate AMPK pathways to regulate glucose metabolism. Research shows galega leaf extract can significantly reduce blood glucose levels and support weight management through improved [insulin sensitivity](/ingredients/condition/weight-management).

## Health Benefits

• [Blood glucose](/ingredients/condition/weight-management) reduction: In diabetic mice, optimized leaf extract (50 mg/kg) reduced blood glucose more effectively than metformin, lowering levels from 325.89 to 205.99 mg/dL (animal evidence only)
• Weight management: 10% w/w galega herb in diet reduced body weight, food intake, and fat mass in normal and obese mice over 28 days (preclinical evidence)
• [Antioxidant activity](/ingredients/condition/antioxidant): Exhibits in vitro antioxidant properties and methylglyoxal trapping capabilities (laboratory evidence only)
• [Digestive enzyme](/ingredients/condition/gut-health) inhibition: Shows sucrase and maltase inhibition comparable to acarbose in vitro (preliminary evidence)
• [Immune support](/ingredients/condition/immune-support) in diabetes: Restored neutrophil pools and inhibited lymphocyte apoptosis in diabetic rat models (animal evidence only)

## Mechanism of Action

Galega's primary bioactive compound galegine activates AMP-activated protein kinase (AMPK) pathways, which enhance glucose uptake in skeletal muscle and suppress hepatic glucose production. The biguanide compounds in galega also inhibit [mitochondrial](/ingredients/condition/energy) respiratory chain complex I, reducing ATP synthesis and activating metabolic regulatory pathways similar to metformin.

## Clinical Summary

Current evidence is limited to animal studies showing promising glucose-lowering effects. In diabetic mice, galega leaf extract at 50 mg/kg reduced [blood glucose](/ingredients/condition/weight-management) from 325.89 to 205.99 mg/dL, outperforming metformin. Additional rodent studies demonstrate that 10% w/w galega in diet reduced body weight, food intake, and fat mass. No human clinical trials have been published to date, limiting evidence strength for therapeutic applications.

## Nutritional Profile

Galega officinalis leaves contain bioactive alkaloids as primary compounds of interest: guanidine derivatives including galegine (isoamylene guanidine) at approximately 0.1–0.5% dry weight, which is the principal pharmacologically active constituent and the structural basis for the development of metformin. Flavonoids are present including kaempferol, quercetin, and luteolin glycosides at estimated 0.5–2% dry weight total. Saponins (galegine-related triterpene saponins) contribute to the plant's bioactive profile. Chromium content is notably present in trace amounts and may contribute synergistically to [glucose metabolism](/ingredients/condition/weight-management) effects. The plant contains tannins (condensed and hydrolysable) at approximately 2–5% dry weight, contributing to [antioxidant activity](/ingredients/condition/antioxidant). Crude protein content in dried leaves is estimated at 15–20% dry weight, characteristic of leguminous plants (Galega belongs to Fabaceae family). Dietary fiber is substantial, estimated at 20–30% dry weight including cellulose and hemicellulose. Mineral content includes potassium, calcium, magnesium, and phosphorus in concentrations typical of leafy legumes. Vitamin C and carotenoids are present in fresh material but degrade significantly upon drying. Chlorogenic acids and other hydroxycinnamic acid derivatives contribute to polyphenol content. Bioavailability note: Galegine is water-soluble and extractable in aqueous and ethanolic preparations; flavonoid glycosides require hydrolysis for optimal absorption; overall bioavailability data in humans is very limited and most compositional data is extrapolated from preclinical extraction studies.

## Dosage & Preparation

No clinically studied human dosages exist. Animal studies used 50 mg/kg optimized leaf extract intraperitoneally or 10% w/w galega herb in diet. Historical therapeutic dose recommended as 4 g/day dried herb. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Galega contains potentially toxic alkaloids and should be used with extreme caution. The plant can cause hypoglycemia, especially when combined with diabetes medications like metformin, insulin, or sulfonylureas. Galega is contraindicated during pregnancy and breastfeeding due to potential teratogenic effects. [Liver function](/ingredients/condition/detox) should be monitored during use due to reports of hepatotoxicity with high doses or prolonged consumption.

## Scientific Research

No human clinical trials, RCTs, or meta-analyses have been conducted on Galega officinalis. All available evidence is limited to preclinical animal studies in diabetic mice and rats, and in vitro laboratory investigations. Human safety and efficacy remain unestablished through clinical research.

## Historical & Cultural Context

Used for centuries in European herbal medicine to alleviate diabetes symptoms, often in mixtures, Galega officinalis influenced the development of metformin. The British Medical Herbal Association recommends it for diabetes mellitus in the UK and Bulgaria, and it has been traditionally employed as a galactogogue to enhance milk production during lactation.

## Synergistic Combinations

Cinnamon, Chromium, Alpha-lipoic acid, Bitter melon, Gymnema sylvestre

## Frequently Asked Questions

### What is the active compound in galega that lowers blood sugar?

Galegine is the primary bioactive compound in galega that lowers blood sugar by activating AMPK pathways. This biguanide alkaloid is actually a precursor to metformin and works through similar glucose-regulating mechanisms.

### How much galega extract was effective in animal studies?

Animal studies used 50 mg/kg of optimized galega leaf extract, which reduced blood glucose from 325.89 to 205.99 mg/dL in diabetic mice. For weight management, 10% w/w galega herb mixed into diet showed significant reductions in body weight and fat mass.

### Can galega be taken with diabetes medications?

Galega should not be combined with diabetes medications without medical supervision due to risk of severe hypoglycemia. The herb can potentiate effects of metformin, insulin, and sulfonylureas, potentially causing dangerously low blood sugar levels.

### Is galega safe during pregnancy?

Galega is not safe during pregnancy and is specifically contraindicated due to potential teratogenic effects. The alkaloids in galega can cross the placental barrier and may cause developmental abnormalities or pregnancy complications.

### What side effects does galega cause?

Galega can cause hypoglycemia, nausea, digestive upset, and potential liver toxicity with prolonged use. The plant contains toxic alkaloids that require careful dosing, and liver function monitoring is recommended during supplementation.

### What is the difference between galega leaf extract and galega seed extract?

Galega leaf extract has been the primary form studied for blood glucose reduction, with research showing significant effects at 50 mg/kg in animal models. Galega seeds are traditionally used but have received less scientific attention for metabolic effects compared to the leaf extract form. The leaf extract appears to deliver higher concentrations of active compounds responsible for glucose-lowering activity based on available preclinical evidence.

### Who would benefit most from taking galega supplementation?

Galega may be of interest to individuals with elevated blood glucose levels, though current evidence is limited to animal studies and historical traditional use. Those seeking weight management support combined with metabolic health may also find galega relevant, given preclinical evidence showing reduced body weight and fat mass in mice. However, anyone with diabetes or metabolic conditions should consult a healthcare provider before use, as galega's effects in humans remain understudied.

### How does the research quality and strength of evidence compare for galega versus established diabetes treatments?

While galega showed superior glucose-reduction effects compared to metformin in diabetic mice (lowering blood glucose from 325.89 to 205.99 mg/dL), this evidence is preclinical and cannot be directly applied to human outcomes. Clinical trials in humans are limited, making it difficult to establish galega as equivalent to pharmaceutical treatments in real-world use. The current evidence base suggests galega warrants further human research, but it should not replace established medical therapies without professional guidance.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*